Spironolactone
Product Images NDC 68071-2977

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-2977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2977 9)

This is a description of a medication, Spironolactone 100mg, that comes in a package of 90 tablets with Lot # 00000 and NDC: 68071-2977-09; Oval in shape, white and scored with MP 303 debossed, the tablet contains Spironolactone, USP.......100mg. The manufacturer NDC is 16714-086-03, and it's expiry date is 00-00. The packaging also contains a warning to keep it out of reach of children and to store it at a controlled temperature of 68-77°F, with a reference number to call in case of side effects.*

FDA Label Image

Structure (Spironolactonens 01)

FDA Label Image

Figure1 (Spironolactonens 02)

FDA Label Image

Figure 2 (Spironolactonens 03)

This text appears to be a tabular data containing certain variables and their values. It is likely to be a medical or clinical study that is examining the effect of various medications on diabetes patients. The variables mentioned are Subgroup, S Creatinine, Potassium, and Beta Blocker. The text also suggests that the study compared the effectiveness of Spironolactone and Placebo, and measured their impact against Blood Pressure at different points in time (02, 04, 06, 08, 10, and 12).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.